Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-12

Clinical Trial Update: Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing safety and tolerability of ophthalmic PRO-179 to Travatan in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRO-179
  • Travatan (travoprost)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Glaucoma | Phase 1 | Status: COMPLETED | Results posted: 2019-12-12